Peer Review History

Original SubmissionJune 16, 2020
Decision Letter - Matteo Bauckneht, Editor

PONE-D-20-17186

Comparative test-retest variability of outcome parameters derived from brain [18F]FDG PET studies in non-human primates

PLOS ONE

Dear Dr. Lavisse,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 24 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Matteo Bauckneht

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for including the following funding statement in the acknowledgements sectionn of your manuscript; "This work was partially funded by ANR-11-INBS-0011 - NeurATRIS: A Translational Research Infrastructure for Biotherapies in Neurosciences."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The authors received no specific funding for this work"

b.  Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement.

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

3.

We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors performed FDG PET brain scans on 6 cynomolgus macaques about one month apart. The parameters include CMRglu, SUVmean, SUVxGlu, SUVRpons and SUVRcerebellum. They also scanned 4 additional animals to see if the values of these parameters fall within the confidence interval defined by the previous 6 animals. The most stable parameter was SUVR with variability between 7-14%, while the variability of CMRglu reached 25-43%. It was concluded SUVR could be used for quantification if pons or crebellum was not affected by the experimental conditions.

This is a well-designed study with clear descriptions of the methodology to allow reproducibility. It provided absolute numbers to compare the variability of various quantification methods across the brain regions. Congratulations to the authors for their deeds and recommendation for publication to share their results.

Reviewer #2: The manuscript presented by Goutal and co-authors explore the repeatability of quantitative parameters from FDG-PET studies in nonhuman primates and also compare them. This is a well-written paper, with a clear and concise text where objectives are well defined, and introduction and discussion supported by a good argumentation. In general, methodology is adequate and experimental methods are described correctly.

However, there are some points that would need to be revised or discussed by the authors in order to improve the quality of the work.

- The authors have carried out a test-retest study controlling all the experimental conditions and have analyzed the reproducibility of the results by the study of intra-subject and inter-subject variability. However, another important measure which can be calculated from test-retest data is the reliability of the measurements by means intraclass correlation coefficient (ICC). Why authors don’t have calculated this coefficient?

- In “PET acquisition” section (page 9, line 130) authors should detail the times at which arterial blood samples were collected to obtain arterial input function.

- For each PET study, authors acquired a 60 min dynamic emission scan (Page 8, line 120). Which temporal sequence did the authors use to reconstruct the studies? Please, explain in “PET acquisition“ section.

- Which statistical test was performed to analyze the homogeneity of experimental conditions (body weight and injected dose)? Please, refer in “Statistical Analyses” section.

- The authors have used a segmentation pipeline to automatically delineate the anatomical regions of interest for each macaque. However, it is usual to spatially normalize brain images to a common stereotaxic space to apply a predetermined template of VOIs. Probably, the method used to quantify the different regions also influences the variability observed in the study. Although the authors discuss the influence of different types of anesthesia on the results of the study (page 19, lines 349-352), it would be also convenient to comment the importance of the quantification method.

- It would be desirable to show a graphical representation of FDG Time Activity Curves of test-retest studies, at least of one of the regions (representative). Likewise, it would be nice to show a representative test-retest PET images of one animal. All this information could be added as supplementary material.

Reviewer #3: Dear authors,

your study is very interesting and carried out very well. Nowadays it is very important to evaluate 18F-FDG PET images, from preclinical with animals to human studies, not just from a qualitative point of view. Some of the common quantitative parameters are still not robust enough to evaluate properly the true effects on the metabolism over time, for example when studying a new drug.

In this article the authors analyze the test-retest variance of many quantitative PET parameters (SUV, CMRglu, SUVxGly, SUV ratio on the pons or on the cerebellum) extracted from brain PET images performed twice on a small group of nonhuman primates (macaques) with a very controlled and reproducible protocol. They validated the results on an independent control group, too.

I think that the article is properly written down with a good depiction of the methods utilized and so, has to be accepted.

Major comment:

- Material and method: you describe in the “animals and housing” paragraph one anesthesia protocol for all procedures, but then it is slightly different for MRI and PET.

- I think that you can add a picture of the PET brain images and a figure of the curve obtained to show the quality of the scan.

- From a qualitative point of view there were any substantial difference between the scans? please add this information

- The mean glycemia level of this group of animals is comparable with other study with the same species? Please add this information

Minor comment:

- Line 63 “by the” is repeated twice

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Reviewer #1: We thank Reviewer#1 for this comment.

Reviewer #2:

-The authors have carried out a test-retest study controlling all the experimental conditions and have analyzed the reproducibility of the results by the study of intra-subject and inter-subject variability. However, another important measure which can be calculated from test-retest data is the reliability of the measurements by means intraclass correlation coefficient (ICC). Why authors don’t have calculated this coefficient?

-> We initially calculated the intraclass correlation coefficient (ICC) which is indeed a widely used reliability index in test-retest, intrarater, and interrater reliability studies. However, some of the ICC values in our study were negative. Although the ICC value should theoretically range between 0 and 1 per se (as it represents the proportionality of the total variance), its estimation may be negative. In these cases, it has been suggested to reset the ICC to 0 but such cases are then uninterpretable (Chen, 2017, Human Brain Mapping, doi: 10.1002/hbm.23909). We therefore chose another option and used a different measure of reliability. We report the mean absolute difference between values from the first and the second scan divided by the mean of both values to reflect the reliability of the measurements.

- In “PET acquisition” section (page 9, line 130) authors should detail the times at which arterial blood samples were collected to obtain arterial input function.

-> This information has been added in the text. Please see page 9 line 131

- For each PET study, authors acquired a 60 min dynamic emission scan (Page 8, line 120). Which temporal sequence did the authors use to reconstruct the studies? Please, explain in “PET acquisition“ section.

->We provided the framing in the “PET acquisition” paragraph. Please see page 9 line 123

- Which statistical test was performed to analyze the homogeneity of experimental conditions (body weight and injected dose)? Please, refer in “Statistical Analyses” section.

-> The homogeneity of experimental conditions (body weight, temperature and injected dose at test and retest) were analyzed using Wilcoxon signed-rank test. We have inserted this information in the “Statistical analysis” paragraph. Please see page 10 line 170.

- The authors have used a segmentation pipeline to automatically delineate the anatomical regions of interest for each macaque. However, it is usual to spatially normalize brain images to a common stereotaxic space to apply a predetermined template of VOIs.

Probably, the method used to quantify the different regions also influences the variability observed in the study.

Although the authors discuss the influence of different types of anesthesia on the results of the study (page 19, lines 349-352), it would be also convenient to comment the importance of the quantification method.

-> We have established that a large part of the test/retest variability was due to global rather than local effects, as the normalized SUV (SUVR) and especially the SUVRcerebellum show low test/retest variability.

In addition, for each animal, the same MRI segmentation was used for the analysis of the test and retest PET scan. Therefore, we would not expect much variability to be introduced by the MRI segmentation. On the other hand, registration errors between the two PET sessions might indeed contribute to the test/retest regional variability, although we expect this effect to remain marginal compared to more global experimental factors affecting SUV and CMRGlu parameters.

We inserted a comment in the Discussion page 19 line 347.

- It would be desirable to show a graphical representation of FDG Time Activity Curves of test-retest studies, at least of one of the regions (representative). Likewise, it would be nice to show a representative test-retest PET images of one animal. All this information could be added as supplementary material.

-> We have added a supplementary Figure (Fig. S1) displaying a)- time activity curves of a representative animal in the thalamus and pons regions and b)- corresponding SUV-normalized PET images in test and retest condition

Reviewer #3:

- Material and method: you describe in the “animals and housing” paragraph one anesthesia protocol for all procedures, but then it is slightly different for MRI and PET.

-> We thank the reviewer for this relevant comment and have clarified this concern in the Methods section. Indeed, in both MRI and PET sessions, anesthesia was induced using a mixture of ketamine and xylazine (10 and 1mg/kg, respectively) in each animal. This information is now clearly reported p7 line 86.

- I think that you can add a picture of the PET brain images and a figure of the curve obtained to show the quality of the scan.

-> According to both reviewers suggestion, SUV values are now corrected and we have added a supplementary Figure (Fig. S1) displaying a)- time activity curves of a representative animal in the thalamus and pons regions and b)- corresponding SUV-normalized PET images in test and retest condition

- From a qualitative point of view there were any substantial difference between the scans? please add this information

-> Visual inspection of the raw and SUV PET images between test and retest scans revealed qualitative difference (see Example in Fig. S1). Actually, this difference was global and not regional. There is indeed a global factor difference between scan and rescan SUV images that is greatly decreased in the normalized SUVr images (especially in SUVr-cerebellum images).

We inserted this information in the Result section. Please see p 12 line 213.

- The mean glycemia level of this group of animals is comparable with other study with the same species? Please add this information

-> Similar glucose levels in cynomolgus macaques (about 5 years old) have previously been reported in few studies (most metabolic studies in primates use the SUV parameter): Wu et al. (2012) reported a glycemia range of 2 to 4 mmol/L in male primates and Guo et al. (2014) found glycemia values around 4.7 mmol/L for instance.

We inserted this information in the Discussion section. Please see p 18 lines 324

Minor comment:

- Line 63 “by the” is repeated twice

-> Thank you, the typo has been corrected.

Attachments
Attachment
Submitted filename: Response-to-Reviewers_final.docx
Decision Letter - Matteo Bauckneht, Editor

Comparative test-retest variability of outcome parameters derived from brain [18F]FDG PET studies in non-human primates

PONE-D-20-17186R1

Dear Dr. Lavisse,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Matteo Bauckneht

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Matteo Bauckneht, Editor

PONE-D-20-17186R1

Comparative test-retest variability of outcome parameters derived from brain [18F]FDG PET studies in non-human primates

Dear Dr. Lavisse:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Matteo Bauckneht

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .